However, JP Morgan analysts maintain a positive outlook for several key players. Eli Lilly And Co. LLY, a top pick for the firm, is projected to see continued growth in its diabetes and obesity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback